Clinical trial
Phase 1-2 Trial of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure
NCT01573286 is registered in ClinicalTrials.gov with Alberta Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1-2 Trial of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure
- Lead sponsor
- Alberta Children's Hospital
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- January 31, 2012
- Completion date
- August 31, 2015
- Enrollment
- 13 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.